FRA:BOX • US0758871091
The current stock price of BOX.DE is 156.05 EUR. In the past month the price decreased by -12.97%. In the past year, price decreased by -28.55%.
ChartMill assigns a fundamental rating of 4 / 10 to BOX.DE. There are concerns on the financial health of BOX.DE while its profitability can be described as average.
Over the last trailing twelve months BOX.DE reported a non-GAAP Earnings per Share(EPS) of 11.81. The EPS decreased by -0.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.68% | ||
| ROA | 3.03% | ||
| ROE | 6.61% | ||
| Debt/Equity | 0.73 |
18 analysts have analysed BOX.DE and the average price target is 183.58 EUR. This implies a price increase of 17.64% is expected in the next year compared to the current price of 156.05.
For the next year, analysts expect an EPS growth of 3.1% and a revenue growth 2.07% for BOX.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 16.06 | 108.279B | ||
| 2M6 | MEDTRONIC PLC | 15.75 | 106.138B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.83 | 47.771B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.35 | 25.421B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.31 | 25.364B | ||
| BIM | BIOMERIEUX | 19.03 | 11.274B | ||
| DIA | DIASORIN SPA | 17.17 | 3.929B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.42 | 3.644B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.4 | 2.406B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.94 | 2.309B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY US
Employees: 74000
Phone: 12018476800
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
The current stock price of BOX.DE is 156.05 EUR. The price increased by 0.61% in the last trading session.
BECTON DICKINSON AND CO (BOX.DE) has a dividend yield of 2.36%. The yearly dividend amount is currently 3.51.
BOX.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
18 analysts have analysed BOX.DE and the average price target is 183.58 EUR. This implies a price increase of 17.64% is expected in the next year compared to the current price of 156.05.
BECTON DICKINSON AND CO (BOX.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
BECTON DICKINSON AND CO (BOX.DE) will report earnings on 2026-04-29.